Drug-Receptor Interactions Flashcards
5 major types of cell receptors
Intracellular Ligand-gated transmembrane proteins Cytokine receptor mechanism Ligand-gated ion channels G-protein family of transmembrane receptors
Cellular membrane components of a ligand-regulated transmembrane enzyme
Cytoplasmic hormone binding domain (TK, SK, or guanalyl cyclase), EC hormone binding domain.
What prolongs the activation of a ligand-regulated transmembrane enzyme?
Autophosphorylation of tyrosine residues
Cytokine receptor mechanisms
Closely resembles tyrosine kinase but utilizes a separate protein tyrosine kinase that binds non-covalently to the membrane
Ligand-gated channel receptors - membrane components
Pentamer: 2 alpha subunits, then beta, delta, and gamma. Drug binds to an alpha subunit.
Common example of a ligand-gated channel receptor
Nicotinic cholinergic receptor
Membrane structure in G-protein coupled receptor
Polypeptide that spans the membrane 7 times, with amino group on the extracellular side and carboxy group in the cytoplasm
Steps involved in the adenylyl cyclase pathway
- Agonist binds and ternary complex forms
- Ternary complex binds GTP rather than GDP
- GTP and alpha subunit dissociate from beta-gamma
- Alpha subunit stimulates breakdown of ATP into cAMP and activates PKA. cAMP and PKA have downstream targets.
- Alpha subunit remains active until the GTPase converts GTP back to GDP.
- Non-active alpha subunit with bound GDP reforms the ternary complex
Describe the steps involved in receptor signaling via the phospholipase C pathway
- Agonist binds and ternary complex forms
- Ternary complex binds GTP rather than GDP
- GTP and alpha subunit dissociate from beta-gamma
- Alpha subunit stimulates PLC, which will facilitate breakdown of PIP2 into IP3 and DAG. IP3 stimulates release of intracellular calcium from the ER, activating calmodulin. DAG activates PKC.
- Alpha subunit remains active until the GTPase converts GTP back to GDP.
- Non-active alpha subunit with bound GDP reforms the ternary complex
Three ways by which drugs can produce beneficial vs toxic
Actions at the same receptor, producing direct extension of the drug
Actions at the same receptors at different tissues
Actions by different types of receptors
Idiosyncratic drug response
Unusual response that is not frequently observed in the majority of patients
Tachyphylaxis
Rapid development of diminished responsiveness after administration of a drug
Pharmacodynamic tolerance - different methods
Binding of beta-arrestin
Loss of membrane-bound receptors
Uncoupling from post-receptor moieties from functional modification of G-proteins and/or subsequent second messenger enzymes
Mechanism of homologous desensitization
GRK2 and GRK3 functionally uncouple receptors and trigger sequestration from the cell
Mechanism of heterologous desensitization
Several protein kinases promote phosphorylation of receptors, PKA, and PKC. This functionally uncouples receptors and impairs interactions with G-proteins